CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Vaidya Sane Ayurved Laboratories Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Vaidya Sane Ayurved Laboratories Ltd
Shukrawar Peth
Fl. 5, 1047, Shriram Bhawan
THANE, 400604  India Ticker: MADHAVBAUGMADHAVBAUG

Business Summary
Vaidya Sane Ayurved Laboratories Limited is an India-based company, which is engaged in research and development in ayurvedic medicines and the sale of ayurvedic medicines and products through its various franchises and own clinics. The Company is involved in providing ayurved medical professional services across its various clinics, including panchkarma and other ayurvedic treatments through the running of ayurvedic hospitals. The Company operates under brand Madhavbaug. It uses diagnostics, diet, physiotherapy and ayurveda to provide heart disease, diabetes, hypertension and obesity reversal treatments to its patients. The Company operates approximately 350 clinics across Maharashtra, Madhya Pradesh, Gujarat, Uttar Pradesh, Goa, Karnataka, Delhi, Punjab, Uttarakhand, West Bengal, and Chhattisgarh. The Company operates three cardiac prevention and rehabilitation hospitals in Khopoli, Kondhali, and Vishakhapatnam.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/20243/31/2024-----

General Information
Number of Employees: 636 (As of 3/31/2024)
Outstanding Shares: 10,513,450 (As of 9/30/2024)
Stock Exchange: NSE


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, December 2, 2024